Dr. Mark Duggan, Vice President in the Neuroscience iMed, was most recently VP of Scientific Operations at SciFluor Life Sciences where he helped shape the business plan and vision for the early-stage biotechnology company. Prior to that Mark served as VP of Chemistry and Preclinical Development and as a key member of the executive team at Link Medicine. Previously Mark headed the Medicinal Chemistry Department at Amgen, Cambridge after rising to Senior Director of Medicinal Chemistry at Merck Research Laboratories. At both of these companies Mark contributed to the strategic direction of drug discovery programs and played a lead role in the delivery of numerous development candidates across diverse therapeutic areas. Mark earned his BS in Chemistry from The Pennsylvania State University and PhD in Organic Chemistry from the University of Pennsylvania.